Abbott beats quarterly profit estimate on strong demand for diabetes devices

featured-image

The company also maintained its full-year profit forecast of $5.05 to $5.25 per share in the face of an escalating global trade war. Abbott is likely to face a hit from the heavy duties imposed on other countries given its broad manufacturing footprint across the world, according to analysts. On an adjusted basis, the company's quarterly profit of $1.09 per share beat analysts' average expectations of $1.07 per share, according to estimates compiled by LSEG.

The company also maintained its full-year profit forecast of $5.05 to $5.25 per share in the face of an escalating global trade war.

Abbott is likely to face a hit from the heavy duties imposed on other countries given its broad manufacturing footprint across the world, according to analysts. On an adjusted basis, the company's quarterly profit of $1.09 per share beat analysts' average expectations of $1.



07 per share, according to estimates compiled by LSEG..